4//SEC Filing
Allouche Cyril 4
Accession 0001479290-18-000093
CIK 0001479290other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 8:20 PM ET
Size
4.8 KB
Accession
0001479290-18-000093
Insider Transaction Report
Form 4
Allouche Cyril
Principal Financial Officer
Transactions
- Other
Common Stock
2018-06-29$23.33/sh+393$9,170→ 5,143 total
Footnotes (1)
- [F1]These shares were acquired by Mr. Allouche under the Issuer's 2014 Employee Stock Purchase Plan on June 29, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001744573
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 8:20 PM ET
- Size
- 4.8 KB